284 related articles for article (PubMed ID: 30507707)
1. Apolipoprotein L1 and kidney transplantation.
Tedla FM; Yap E
Curr Opin Organ Transplant; 2019 Feb; 24(1):97-102. PubMed ID: 30507707
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Injury in APOL1-associated Kidney Disease.
Ma L; Divers J; Freedman BI
Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
[TBL] [Abstract][Full Text] [Related]
3. Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation.
Chen DP; Zaky ZS; Schold JD; Herlitz LC; El-Rifai R; Drawz PE; Bruggeman LA; Barisoni L; Hogan SL; Hu Y; O'Toole JF; Poggio ED; Sedor JR
Clin Transplant; 2021 Apr; 35(4):e14234. PubMed ID: 33511679
[TBL] [Abstract][Full Text] [Related]
4. The APOL1 gene and allograft survival after kidney transplantation.
Reeves-Daniel AM; DePalma JA; Bleyer AJ; Rocco MV; Murea M; Adams PL; Langefeld CD; Bowden DW; Hicks PJ; Stratta RJ; Lin JJ; Kiger DF; Gautreaux MD; Divers J; Freedman BI
Am J Transplant; 2011 May; 11(5):1025-30. PubMed ID: 21486385
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
[TBL] [Abstract][Full Text] [Related]
6. APOL1 high-risk genotypes and renal transplantation.
Shah S; Shapiro R; Murphy B; Menon MC
Clin Transplant; 2019 Jun; 33(6):e13582. PubMed ID: 31050035
[TBL] [Abstract][Full Text] [Related]
7. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
Semin Nephrol; 2017 Nov; 37(6):530-537. PubMed ID: 29110760
[TBL] [Abstract][Full Text] [Related]
9.
Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
[TBL] [Abstract][Full Text] [Related]
10. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
11. APOL1 Genetic Testing in Living Kidney Transplant Donors.
Mohan S; Iltis AS; Sawinski D; DuBois JM
Am J Kidney Dis; 2019 Oct; 74(4):538-543. PubMed ID: 30982552
[TBL] [Abstract][Full Text] [Related]
12. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.
Julian BA; Gaston RS; Brown WM; Reeves-Daniel AM; Israni AK; Schladt DP; Pastan SO; Mohan S; Freedman BI; Divers J
Am J Transplant; 2017 Jun; 17(6):1540-1548. PubMed ID: 27862962
[TBL] [Abstract][Full Text] [Related]
13. APOL1 risk variants in kidney transplantation: a modulation of immune cell function.
Malone AF
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779415
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
Young BA; Blacksher E; Cavanaugh KL; Freedman BI; Fullerton SM; Kopp JB; Umeukeje EM; West KM; Wilson JG; Burke W;
Am J Nephrol; 2019; 50(4):303-311. PubMed ID: 31480040
[TBL] [Abstract][Full Text] [Related]
15. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
[TBL] [Abstract][Full Text] [Related]
16. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.
Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein L1: role in the evaluation of kidney transplant donors.
Lentine KL; Mannon RB
Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):645-655. PubMed ID: 33009133
[TBL] [Abstract][Full Text] [Related]
18. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.
Ross LF; Thistlethwaite JR
Prog Transplant; 2016 Sep; 26(3):203-6. PubMed ID: 27302054
[TBL] [Abstract][Full Text] [Related]
19. A Focus Group Study on African American Living Donors' Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing.
Gordon EJ; Amórtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Prog Transplant; 2019 Sep; 29(3):239-247. PubMed ID: 31146624
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Locke JE; Sawinski D; Reed RD; Shelton B; MacLennan PA; Kumar V; Mehta S; Mannon RB; Gaston R; Julian BA; Carr JJ; Terry JG; Kilgore M; Massie AB; Segev DL; Lewis CE
Ann Surg; 2018 Jun; 267(6):1161-1168. PubMed ID: 28187045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
